In a nutshell The aim of this study was to examine the effect of long-acting exenatide on blood sugar control, body weight and the thickness of the wall of the carotid artery in patients with type 2 diabetes (T2D). The main finding of the study was that this treatment improved all these parameters in patients with T2D. Some background Patients withT2D...
Read More
In a nutshell This study investigated the safety and effectiveness of albiglutide (Tanzeum) in preventing cardiovascular events (CVE) such as heart attacks and strokes in patients with type 2 diabetes (T2D) and heart disease. The main finding was that albiglutide reduced the risk of CVE in these patients. Some background Patients with...
Read MoreIn a nutshell This phase 3 clinical trial is investigating the effects of pemafibrate (Parmodia) on cardiovascular disease in people with type 2 diabetes (T2D). The main outcome to be measured will be the number of patients that experience a heart attack, stroke, death from cardiovascular causes, or who have to be hospitalized for unstable angina (severe...
Read More
